Isolated limb perfusion with chemotherapeutic agents for melanoma: A reevaluation of drug dosimetry
- 1 October 1989
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (10) , 1393-1397
- https://doi.org/10.1016/0277-5379(89)90095-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanomaCancer, 1988
- Regional perfusion: Current sophistication, what next?Cancer, 1986
- A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanomaCancer, 1985
- Dosimetry of cytostatics in hyperthermic regional isolated perfusionCancer, 1985
- A Prospective Randomized Study of Regional Extremity Perfusion in Patients with Malignant MelanomaAnnals of Surgery, 1984
- Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactionsEuropean Journal of Cancer and Clinical Oncology, 1982
- Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremitiesCancer, 1976
- Chemotherapy of Melanoma of the Extremities by PerfusionAnnals of Surgery, 1972
- Experience with 1-phenylalanine mustard dihydrochloride in isolation-perfusion of extremities for malignant melanomaCancer, 1971
- Chemotherapy of CancerAnnals of Surgery, 1958